A shorter MPFI designed specifically for patients with chronic pain proved generally valid and reliable on a group level, according to a recent study.

Certain drugs and a host of nonpharmacologic therapies are key to treating patients who have nociplastic pain, a relatively ...

AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...

Scientists have developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce pain and disability for people ...

To manage the daily pain, frequent brain fog, and sporadic days of full-body exhaustion, my primary care doctor suggested a ...

Results of a database review revealed duloxetine, pregabalin, and milnacipran as the only effective pharmacological therapies for managing pain in fibromyalgia.

Right now, the FDA has approved the new drug to treat pain from an injury or surgery. Its manufacturer is also testing it for ...

The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.

On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...

In fact, there is no specific mattress that’s best for back pain. Instead, people with back pain should look for mattresses that feel medium-firm to you. Those beds have the best chance of ...

Atreon Orthopedics earned FDA 510(k) clearance for the BioCharge autobiologic matrix and launched the new product, according to a Feb. 20 news release.

Researchers say an epidural injection can provide relief for chronic back pain but it's not a permanent solution.